Document is current
Any future updates will be listed below
-
Authors
Vesikansa, Aino
Mehtälä, Juha
Aspholm, Susanna
Kallio-Grönroos, Kirsi
Mutanen, Katja
Lundqvist, Annamari
Laatikainen, Tiina
Saukkonen, Tero
Pietiläinen, Kirsi H.
-
Funding
Funding for this research was provided by:
Novo Nordisk
- License Information
-
More Information
Article History
Received: 26 April 2024
Accepted: 29 April 2025
First Online: 10 May 2025
Declarations
:
: The FinHealth 2017 Survey received approval from the Coordinating Ethics Committee at the Hospital District of Helsinki and Uusimaa (Ref 37/13/03/00/2016). All FinHealth 2017 study participants had filled informed consent for a biobank study. Permission to use the FinHealth 2017 data in present study was granted by the THL Biobank. Permission for the data collection and linkage from the Care Register for Health Care and the Register of Primary Health Care Visits was granted by the Finnish Institute for Health and Welfare. Permission for data collection and linkage from the Prescription Centre was approved by The Social Insurance Institution of Finland. All data were analyzed in a pseudonymized format.
: No individual-level data are reported in this study. Not applicable.
: AV and JM are employees of MedEngine Oy. TS, KM, and SA are employees of Novo Nordisk. KKG was an employee of Novo Nordisk at the time of manuscript preparation. TS owns shares in Novo Nordisk. AL, TL, and KHP have no competing interests.
